Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 928 products on this category.

Product data	Purity	Price range	Estimated delivery
Carfilzomib Impurity 30 REF: 4Z-C-121033	- - -	To inquire	Tue 17 Dec 24
Palbociclib Impurity 58 REF: 4Z-P-196065CAS: 2363172-64-7	- - -	To inquire	Tue 17 Dec 24
Olaparib Impurity 29 REF: 4Z-O-032031	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 62 REF: 4Z-E-068007CAS: 749927-69-3	- - -	To inquire	Tue 17 Dec 24
Desfluoroenzalutamide REF: 4Z-E-068012CAS: 915087-16-0	- - -	To inquire	Tue 17 Dec 24
Abiraterone Impurity 20 REF: 4Z-A-8230CAS: 2484719-17-5	- - -	To inquire	Tue 17 Dec 24
Carfilzomib Impurity 3 REF: 4Z-C-121006	- - -	To inquire	Tue 17 Dec 24
Lenvatinib Impurity 11 REF: 4Z-L-124015	- - -	To inquire	Tue 17 Dec 24
Palbociclib Impurity 35 REF: 4Z-P-196042CAS: 775288-71-6	- - -	To inquire	Tue 17 Dec 24
Leuprorelin (Leuprolide) EP Impurity H REF: 4Z-PL-4110CAS: 112710-58-4	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 8 (Intedanib Impurity 8) REF: 4Z-N-066017CAS: 2093243-16-2	- - -	To inquire	Tue 17 Dec 24
S-Deoxo-δ-6, 7-Fulvestrant REF: 4Z-F-3118CAS: 2170200-16-3	- - -	To inquire	Tue 17 Dec 24
Leuprorelin (Leuprolide) EP Impurity A Ditrifluoroacetate REF: 4Z-PL-4125CAS: 62621-13-0	- - -	To inquire	Tue 17 Dec 24
Goserelin EP Impurity E Tritrifluoroacetate REF: 4Z-PG-155CAS: 147688-42-4	- - -	To inquire	Tue 17 Dec 24
Lenvatinib Impurity 4 REF: 4Z-L-124007CAS: 2380197-90-8	- - -	To inquire	Tue 17 Dec 24
6-Keto Fulvestrant REF: 4Z-F-3112CAS: 2858589-78-1	- - -	To inquire	Tue 17 Dec 24
Leuprorelin (Leuprolide) Impurity 7 Ditrifluoroacetate REF: 4Z-PL-4126	- - -	To inquire	Tue 17 Dec 24
Carfilzomib Impurity 22 REF: 4Z-C-121025CAS: 2049025-45-6	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 70 (Intedanib Impurity 70) REF: 4Z-N-066004	- - -	To inquire	Tue 17 Dec 24
Leuprorelin (Leuprolide) Impurity 10 Ditrifluoroacetate REF: 4Z-PL-4131CAS: 112642-14-5	- - -	To inquire	Tue 17 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Carfilzomib Impurity 30

Ref: 4Z-C-121033

Palbociclib Impurity 58

Ref: 4Z-P-196065

Olaparib Impurity 29

Ref: 4Z-O-032031

Enzalutamide Impurity 62

Ref: 4Z-E-068007

Desfluoroenzalutamide

Ref: 4Z-E-068012

Abiraterone Impurity 20

Ref: 4Z-A-8230

Carfilzomib Impurity 3

Ref: 4Z-C-121006

Lenvatinib Impurity 11

Ref: 4Z-L-124015

Palbociclib Impurity 35

Ref: 4Z-P-196042

Leuprorelin (Leuprolide) EP Impurity H

Ref: 4Z-PL-4110

Nintedanib Impurity 8 (Intedanib Impurity 8)

Ref: 4Z-N-066017

S-Deoxo-δ-6, 7-Fulvestrant

Ref: 4Z-F-3118

Leuprorelin (Leuprolide) EP Impurity A Ditrifluoroacetate

Ref: 4Z-PL-4125

Goserelin EP Impurity E Tritrifluoroacetate

Ref: 4Z-PG-155

Lenvatinib Impurity 4

Ref: 4Z-L-124007

6-Keto Fulvestrant

Ref: 4Z-F-3112

Leuprorelin (Leuprolide) Impurity 7 Ditrifluoroacetate

Ref: 4Z-PL-4126

Carfilzomib Impurity 22

Ref: 4Z-C-121025

Nintedanib Impurity 70 (Intedanib Impurity 70)

Ref: 4Z-N-066004

Leuprorelin (Leuprolide) Impurity 10 Ditrifluoroacetate

Ref: 4Z-PL-4131